Boehringer Ingelheim progresses to 6th place in the 2026 Access to Medicine IndexCompany performs above average across all three assessed areas, with significant progress in Governance of Access and Product DeliveryLong-term health equity initiatives, partnerships, open innovation and stronger outcome…